Results 171 to 180 of about 7,423,179 (348)
Residual decontamination chemical agents negatively affect adhesion and proliferation of osteoblast-like cells on implant surface. [PDF]
Balderrama ÍF +6 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
James Geoghegan, Jeffrey L Tong
openaire +1 more source
ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery. [PDF]
Bou A +12 more
europepmc +1 more source
New chemical agents based on adamantane-monoterpene conjugates against orthopoxvirus infections. [PDF]
Suslov EV +10 more
europepmc +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Environmental and Occupational Exposure to Chemical Agents and Health Challenges I-What Message Can Bring to Regulatory Science? [PDF]
Ladeira C.
europepmc +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source

